Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.

Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, Brennan P, Boffetta P, Yoshida T.

Int J Cancer. 2009 Aug 15;125(4):837-43. doi: 10.1002/ijc.24434.

2.

Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.

Long JR, Cai Q, Shu XO, Cai H, Gao YT, Zheng W.

Pharmacogenet Genomics. 2007 May;17(5):331-8.

PMID:
17429315
3.

Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.

Breast Cancer Res Treat. 2009 Mar;114(2):327-38. doi: 10.1007/s10549-008-9998-0. Epub 2008 Jul 16.

PMID:
18629629
4.

Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.

Long JR, Egan KM, Dunning L, Shu XO, Cai Q, Cai H, Dai Q, Holtzman J, Gao YT, Zheng W.

Pharmacogenet Genomics. 2006 Apr;16(4):237-43.

PMID:
16538170
5.

Polymorphisms in steroid hormone pathway genes and mammographic density.

Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C.

Breast Cancer Res Treat. 2003 Jan;77(1):27-36.

PMID:
12602902
6.

Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.

Breast Cancer Res Treat. 2010 Jan;119(2):463-74. doi: 10.1007/s10549-009-0407-0. Epub 2009 May 8. Erratum in: Breast Cancer Res Treat. 2010 Jan;119(2):475.

PMID:
19424794
7.

Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.

Miyoshi Y, Noguchi S.

Biomed Pharmacother. 2003 Dec;57(10):471-81. Review.

PMID:
14637391
8.
9.

Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.

Han DF, Zhou X, Hu MB, Xie W, Mao ZF, Chen DE, Liu F, Zheng F.

Chin Med J (Engl). 2005 Sep 20;118(18):1507-16.

PMID:
16232327
10.

Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.

Ferlin A, Ganz F, Pengo M, Selice R, Frigo AC, Foresta C.

Endocr Relat Cancer. 2010 Jan 29;17(1):17-25. doi: 10.1677/ERC-09-0176. Print 2010 Mar.

PMID:
19776291
11.

Polymorphisms in genes involved in the estrogen pathway and mammographic density.

Dumas I, Diorio C.

BMC Cancer. 2010 Nov 22;10:636. doi: 10.1186/1471-2407-10-636.

12.

Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.

Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, Heinze G, Leodolter S, Schneeberger C, Mueller MW, Muendlein A, Koelbl H.

Cancer. 2004 Jul 15;101(2):264-9.

13.

Variability in estrogen-metabolizing genes and their association with genomic instability in untreated breast cancer patients and healthy women.

dos Santos RA, Teixeira AC, Mayorano MB, Carrara HH, de Andrade J, Takahashi CS.

J Biomed Biotechnol. 2011;2011:571784. doi: 10.1155/2011/571784. Epub 2011 Jun 14.

14.

Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.

Wang Q, Li H, Tao P, Wang YP, Yuan P, Yang CX, Li JY, Yang F, Lee H, Huang Y.

DNA Cell Biol. 2011 Aug;30(8):585-95. doi: 10.1089/dna.2010.1195. Epub 2011 Mar 27.

PMID:
21438753
15.

Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.

Greenlee H, Chen Y, Kabat GC, Wang Q, Kibriya MG, Gurvich I, Sepkovic DW, Bradlow HL, Senie RT, Santella RM, Ahsan H.

Breast Cancer Res Treat. 2007 Mar;102(1):111-7. Epub 2006 Jul 19.

PMID:
16850246
16.

Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.

Diergaarde B, Potter JD, Jupe ER, Manjeshwar S, Shimasaki CD, Pugh TW, Defreese DC, Gramling BA, Evans I, White E.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1751-9. doi: 10.1158/1055-9965.EPI-08-0168.

17.

Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.

Yuan X, Zhou G, Zhai Y, Xie W, Cui Y, Cao J, Zhi L, Zhang H, Yang H, Zhang X, Qiu W, Peng Y, Zhang X, Yu L, Xia X, He F.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3621-7. doi: 10.1158/1055-9965.EPI-08-0742.

18.

Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study.

Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1998-2003.

19.

Variants of estrogen-related genes and breast cancer risk in European and African American women.

Quan L, Hong CC, Zirpoli G, Roberts MR, Khoury T, Sucheston-Campbell LE, Bovbjerg DH, Jandorf L, Pawlish K, Ciupak G, Davis W, Bandera EV, Ambrosone CB, Yao S.

Endocr Relat Cancer. 2014;21(6):853-64. doi: 10.1530/ERC-14-0250. Epub 2014 Sep 16.

20.

Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer.

Khvostova EP, Pustylnyak VO, Gulyaeva LF.

Genet Test Mol Biomarkers. 2012 Mar;16(3):167-73. doi: 10.1089/gtmb.2011.0131. Epub 2011 Oct 6.

PMID:
21977969

Supplemental Content

Support Center